4-heptyl-N-((2R,3R,E)-3-hydroxyheptadec-4-en-2-yl)benzamide

ID: ALA4848172

Chembl Id: CHEMBL4848172

PubChem CID: 164614882

Max Phase: Preclinical

Molecular Formula: C31H53NO2

Molecular Weight: 471.77

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](C)NC(=O)c1ccc(CCCCCCC)cc1

Standard InChI:  InChI=1S/C31H53NO2/c1-4-6-8-10-11-12-13-14-15-16-18-20-22-30(33)27(3)32-31(34)29-25-23-28(24-26-29)21-19-17-9-7-5-2/h20,22-27,30,33H,4-19,21H2,1-3H3,(H,32,34)/b22-20+/t27-,30-/m1/s1

Standard InChI Key:  IAAXYWPJHOANQE-WEHDIPTCSA-N

Alternative Forms

  1. Parent:

    ALA4848172

    ---

Associated Targets(Human)

ASAH2 Tchem Neutral ceramidase (95 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ASAH1 Tchem Acid ceramidase (411 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Asah2 Neutral ceramidase (6 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Acer3 Alkaline ceramidase 3 (54 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.77Molecular Weight (Monoisotopic): 471.4076AlogP: 8.55#Rotatable Bonds: 21
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 10.02CX LogD: 10.02
Aromatic Rings: 1Heavy Atoms: 34QED Weighted: 0.14Np Likeness Score: 0.37

References

1. Bielsa N, Casasampere M, Aseeri M, Casas J, Delgado A, Abad JL, Fabriàs G..  (2021)  Discovery of deoxyceramide analogs as highly selective ACER3 inhibitors in live cells.,  216  [PMID:33677352] [10.1016/j.ejmech.2021.113296]

Source